These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Protective effects of Ginkgo biloba leaf polysaccharide on nonalcoholic fatty liver disease and its mechanisms. Yan Z; Fan R; Yin S; Zhao X; Liu J; Li L; Zhang W; Ge L Int J Biol Macromol; 2015 Sep; 80():573-80. PubMed ID: 26047899 [TBL] [Abstract][Full Text] [Related]
8. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats]. Zheng LY; Pan JQ; Lv JH Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135 [TBL] [Abstract][Full Text] [Related]
9. Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease. Heeba GH; Morsy MA Environ Toxicol Pharmacol; 2015 Nov; 40(3):907-14. PubMed ID: 26498267 [TBL] [Abstract][Full Text] [Related]
10. Out of the frying pan: dietary saturated fat influences nonalcoholic fatty liver disease. Parks E; Yki-Järvinen H; Hawkins M J Clin Invest; 2017 Feb; 127(2):454-456. PubMed ID: 28112684 [TBL] [Abstract][Full Text] [Related]
11. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance. Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886 [TBL] [Abstract][Full Text] [Related]
12. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling. Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633 [TBL] [Abstract][Full Text] [Related]
13. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes]. Huang Y; Fu JF; Shi HB; Liu LR Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695 [TBL] [Abstract][Full Text] [Related]
14. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats. Elshazly SM Eur J Pharmacol; 2015 Feb; 748():123-32. PubMed ID: 25542756 [TBL] [Abstract][Full Text] [Related]
15. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver. Xing LJ; Zhang L; Liu T; Hua YQ; Zheng PY; Ji G Eur J Pharmacol; 2011 Oct; 668(3):467-71. PubMed ID: 21839075 [TBL] [Abstract][Full Text] [Related]
16. Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats. Akaslan SB; Degertekin CK; Yilmaz G; Cakir N; Arslan M; Toruner FB Metab Syndr Relat Disord; 2013 Aug; 11(4):243-50. PubMed ID: 23544853 [TBL] [Abstract][Full Text] [Related]
17. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD. Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634 [TBL] [Abstract][Full Text] [Related]
18. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease. Sunny NE; Kalavalapalli S; Bril F; Garrett TJ; Nautiyal M; Mathew JT; Williams CM; Cusi K Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E311-9. PubMed ID: 26058864 [TBL] [Abstract][Full Text] [Related]
19. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121 [TBL] [Abstract][Full Text] [Related]
20. Effect of eicosapentaenoic acid ethyl ester v. oleic acid-rich safflower oil on insulin resistance in type 2 diabetic model rats with hypertriacylglycerolaemia. Minami A; Ishimura N; Sakamoto S; Takishita E; Mawatari K; Okada K; Nakaya Y Br J Nutr; 2002 Feb; 87(2):157-62. PubMed ID: 11895168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]